发明名称 |
Combination therapies with ftc for the treatment of hepatitis b virus infection |
摘要 |
<p>L-FMAU administered in combination and/or alternation with FTC and in combination and/or alternation with an interferon, such as interferon alpha or interferon gamma provides superior therapy in humans against hepatitis B virus.</p> |
申请公布号 |
AU2003253894(A8) |
申请公布日期 |
2004.02.02 |
申请号 |
AU20030253894 |
申请日期 |
2003.07.15 |
申请人 |
TRIANGLE PHARMACEUTICALS, INC. |
发明人 |
PHILIP A. FURMAN |
分类号 |
A61K31/513;A61K31/7072;A61K38/19;A61K38/20;A61K38/21;A61K45/06;A61P31/20;C07K14/555;(IPC1-7):A61K31/70;C07H19/20;C07H19/16 |
主分类号 |
A61K31/513 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|